XML 36 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Net revenues $ 7,911 $ 7,018 $ 6,928
Cost of revenues 5,424 4,840 4,988
Gross profit 2,487 2,178 1,940
Selling, general, and administrative expenses 1,933 1,694 1,581
Operating income 554 484 359
Interest expense, net 141 146 145
Investment expense (income) and other, net 0 8 (18)
Other expense, net 141 154 127
Income before income taxes 413 330 232
Income tax provision 111 80 79
Net income 302 250 153
Net loss attributable to common shareholders:      
Stock conversion of Series B Preferred Stock 0 (372) 0
Net loss attributable to common shareholders $ (288) $ (224) $ (161)
Net loss per common share (basic) (in dollars per share) $ (0.69) $ (0.56) $ (0.46)
Net loss per common share (diluted) (in dollars per share) $ (0.69) $ (0.56) $ (0.46)
Weighted-average shares outstanding (basic) (in shares) 415,709,895 401,513,646 352,705,274
Weighted-average shares outstanding (diluted) (in shares) 415,709,895 401,513,646 352,705,274
Series A Preferred Stock      
Net loss attributable to common shareholders:      
Stock dividend attributable to Series Preferred Stock $ (590) $ (95) $ (270)
Series B Preferred Stock      
Net loss attributable to common shareholders:      
Stock dividend attributable to Series Preferred Stock $ 0 $ (7) $ (44)